| Literature DB >> 25356832 |
Yunzhou Fan1, Zhaoxia Wei2, Weiwei Wang3, Li Tan1, Hongbo Jiang1, Lihong Tian1, Yuguang Cao1, Shaofa Nie1.
Abstract
Surgical site infection (SSI) is one of the most common surgical complications in the world, particularly in developing countries. This study aimed to estimate the incidence and distribution of SSI in mainland China. Eighty-four prospective observational studies (82 surveillance studies, 1 nested case control study, and 1 cohort study) were selected for inclusion in this meta-analysis. The average incidence of SSI in mainland China was 4.5% (95% CI: 3.1-5.8) from 2001 to 2012 and has decreased significantly in recent years. The remote western regions had a higher incidence of 4.6% (95% CI: 4.0-5.3). The most common surgical procedure was abdominal surgery (8.3%, 95% CI: 6.5-10.0). SSI occurred frequently in the elderly (5.1%, 95% CI: 2.2-8.0), patients confined to hospital for over 2 weeks (5.7%, 95% CI: 0.9-10.0), superficial incision wounds (5.6%, 95% CI: 4.4-6.8), dirty wounds (8.7%, 95% CI: 6.9-10.6), operations lasting for over 2 hours (7.3%, 95% CI: 4.9-9.7), general anaesthesia operations (4.7%, 95% CI: 2.7-6.6), emergency surgeries (5.9%, 95% CI: 4.2-7.7), and non-intra-medication operations (7.4%, 95% CI: 1.0-13.7).Entities:
Mesh:
Year: 2014 PMID: 25356832 PMCID: PMC4214160 DOI: 10.1038/srep06783
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Flow diagram for selection process.
The results of pooled incidence of SSI and subgroup analysis by study setting
| Subgroups | No. of studies | Incidence of ISS% (95% CI) | I2 (%) | |
|---|---|---|---|---|
| All studies | 84 | 4.5 (3.1,5.8) | 98.3 | |
| Year | ||||
| Before 2005 | 30 | 4.5 (2.3,6.6) | 95.3 | 0.045 |
| After 2005 | 54 | 3.1 (2.8,3.5) | 98.2 | |
| Region | ||||
| Eastern coastal | 40 | 3.0 (2.4,3.5) | 98.1 | 0.017 |
| Midlands | 24 | 3.8 (1.4,6.7) | 99.1 | |
| Remote western | 18 | 4.6 (4.0,5.1) | 94.9 | |
| Hospital rank | ||||
| Grade III | 64 | 4.3 (2.7,5.9) | 98.7 | 0.793 |
| Grade II | 11 | 3.5 (2.6,4.5) | 95.8 | |
| Surveillance implementation | ||||
| <1 year | 24 | 3.6 (2.9,4.4) | 96.6 | 0.762 |
| 1–3 years | 21 | 2.7 (2.1,3.3) | 97.6 | |
| >3 years | 39 | 5.2 (2.7,7.7) | 99.0 | |
| Surgical procedure | ||||
| General surgery | 45 | 3.1 (1.0,5.2) | 98.9 | 0.004 |
| Abdominal surgery | 15 | 8.3 (6.5,10.0) | 95.6 | |
| Gynaecology & obstetrics | 8 | 5.7 (0.9,13.9) | 93.2 | |
| Neurosurgery | 6 | 3.6 (1.4,5.8) | 93.3 | |
| Thoracic surgery | 5 | 3.0 (2.7,3.3) | 97.7 | |
| Orthopaedic surgery | 4 | 1.0 (0.5,1.6) | 90.3 | |
| Confounding factors control | ||||
| Adjusted | 53 | 3.6 (1.9,5.3) | 94.8 | 0.815 |
| Crude | 31 | 5.1 (2.5,7.9) |
*The SSI incidence was adjusted by at least one confounding factor.
P values test homogeneity between strata with the Wilcoxon or Kruskal-Wallis non-parametric rank test according to the numbers of strata.
Random effects model was use to pool incidences.
Figure 2Pooled incidence of SSI in mainland China at different study periods, with corresponding 95% confidence interval.
The results of subgroup analysis by characteristics of the population
| Subgroups | No. of studies | Incidence of ISS% (95% CI) | I2 (%) | |
|---|---|---|---|---|
| Age | ||||
| ≥60 years old | 22 | 5.1 (2.1, 8.0) | 89.2 | 0.043 |
| <60 years old | 21 | 4.4 (2.0, 6.3) | 98.5 | |
| Sex | ||||
| Male | 8 | 4.6 (3.1, 6.1) | 97.1 | 0.294 |
| Female | 10 | 3.2 (1.7, 4.6) | 95.0 | |
| Wound contamination | ||||
| Dirty | 20 | 8.7 (6.9, 10.6) | 90.1 | 0.001 |
| Contamination | 29 | 3.5 (2.8, 4.3) | 97.8 | |
| Clear | 23 | 0.8 (0.6, 1.0) | 93.0 | |
| Wound depth | ||||
| Superficial | 7 | 5.6 (4.4, 6.8) | 97.6 | 0.006 |
| Deep | 7 | 3.4 (2.9, 4.0) | 98.8 | |
| Operational duration | ||||
| ≥2 hours | 20 | 7.3 (4.9, 9.7) | 90.9 | 0.001 |
| <2 hours | 20 | 2.1 (1.4, 2.8) | 95.9 | |
| Anaesthetic method | ||||
| General | 6 | 4.7 (2.7, 6.6) | 88.0 | 0.001 |
| Local | 7 | 3.2 (2.8, 4.5) | 78.6 | |
| Surgical property | ||||
| Emergency | 11 | 5.9 (4.2, 7.7) | 84.6 | 0.004 |
| Elective | 12 | 4.1 (3.2, 5.0) | 89.0 | |
| Medication timing | ||||
| Post-operation | 6 | 7.4 (1.0, 13.7) | 94.2 | 0.001 |
| Intra-operation | 6 | 2.7 (0.4, 5.0) | 86.8 | |
| Stay length | ||||
| ≥2 weeks | 7 | 5.7 (0.9, 10.4) | 85.7 | 0.001 |
| <2 weeks | 7 | 3.6 (0.01, 8.2) | 89.4 | |
| Season | ||||
| Spring | 9 | 4.5 (3.7, 5.3) | 91.1 | 0.714 |
| Summer | 9 | 4.9 (3.9, 5.8) | 95.6 | |
| Autumn | 9 | 4.3 (3.6, 5.1) | 94.6 | |
| Winter | 8 | 4.2 (2.8, 5.1) | 96.1 |
Random effects model was use to pool incidences. P values test homogeneity between strata with the Wilcoxon or Kruskal-Wallis non-parametric rank test according to the numbers of strata.
Methodological quality of the studies included in the final meta-analysis
| Quality variable | Quality variable categories | Number of studies | Proportion (%) |
|---|---|---|---|
| External validity | |||
| Representation | The sampling frame is a list of almost every individual within the target population | 51 | 60.7 |
| The sampling frame is a list of just one particular group within the target population (e.g. the elderly, children, or those with underlying diseases such as tumours, hypertension, or obesity) | 33 | 39.3 | |
| Sampling bias | |||
| Sampling method | Census or random selection | 84 | 100.0 |
| Non-random selection or not reported | 0 | 0.0 | |
| Sample size | The sample size is ≥456 | 66 | 78.6 |
| The sample size is <456 | 18 | 21.4 | |
| Nonresponse bias | |||
| Response rate | Response rate is ≥80% | 82 | 97.6 |
| Response rate is <80% or not reported | 2 | 2.4 | |
| Internal validity | |||
| Information bias | |||
| Definition | Definition from the diagnosis standard by the MOH in 2001 | 71 | 84.5 |
| Other diagnosis standard or not reported | 13 | 15.5 | |
| Follow up | Patients are followed up after discharge | 23 | 27.4 |
| Patients are not followed up after discharge or not reported | 61 | 72.6 | |
| Data collection | Data are collected directly from the subjects | 63 | 75.0 |
| Data are collected from a proxy (e.g. medical records, administrative databases) | 21 | 25.0 | |
| Measurement bias | |||
| Measurement | The identification of SSI is based on laboratory test for pathogens | 58 | 69.0 |
| The identification of SSI is not based on laboratory test for pathogens or not reported | 26 | 31.0 | |
| Precise parameter | Adjusted incidence or stratified incidence by risk factors | 53 | 63.1 |
| Crude incidence in general population | 31 | 38.9 |
aThe sample size is estimated given α = 0.05, allowable error δ = 0.02, and expected incidence p = 5.0%.
MOH is the Ministry of Health of China.
Figure 3Incidence of SSI in several countries around the world.
The red bar stands for the pooled incidence in mainland China in our meta-analysis, blue bars stand for incidences from published literatures in developed countries, and green bars stand for incidences from published literatures in developing countries. CAF is short for Central African Republic.